{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T18:22:03Z","timestamp":1786818123166,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["B2022344"],"award-info":[{"award-number":["B2022344"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.molimm.2024.04.011","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T22:55:20Z","timestamp":1714085720000},"page":"144-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prednisone combined with Dihydroartemisinin attenuates systemic lupus erythematosus by regulating M1\/M2 balance through the MAPK signaling pathway"],"prefix":"10.1016","volume":"170","author":[{"given":"Yan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangnong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u2019nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangtang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunrong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.molimm.2024.04.011_bib1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.molimm.2024.04.011_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12016-017-8640-5","article-title":"Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus","volume":"55","author":"Bakshi","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.molimm.2024.04.011_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108229","article-title":"Dietary oleuropein and its new acyl-derivate attenuate murine lupus nephritis through HO-1\/Nrf2 activation and suppressing JAK\/STAT, NF-kappaB, MAPK and NLRP3 inflammasome signaling pathways","volume":"74","author":"Castejon","year":"2019","journal-title":"J. Nutr. Biochem"},{"issue":"23","key":"10.1016\/j.molimm.2024.04.011_bib4","doi-asserted-by":"crossref","first-page":"10466","DOI":"10.7150\/thno.45211","article-title":"Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8(+) T-cell memory in wild-type and humanized mice","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.molimm.2024.04.011_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111433","article-title":"MAP4K family kinases and DUSP family phosphatases in T-cell signaling and systemic lupus erythematosus","volume":"8","author":"Chuang","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib6","first-page":"1089","article-title":"Changes in Th1\/Th2-related cytokine expression in the saliva of patients with recurrent aphthous stomatitis before and after prednisone treatment","volume":"26","author":"Deng","year":"2022","journal-title":"Clin. Oral\u00a0Investig."},{"issue":"6","key":"10.1016\/j.molimm.2024.04.011_bib7","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1002\/jcp.27537","article-title":"Physalin D regulates macrophage M1\/M2 polarization via the STAT1\/6 pathway","volume":"234","author":"Ding","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.molimm.2024.04.011_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175823","article-title":"Luteolin attenuates lupus nephritis by regulating macrophage oxidative stress via HIF-1alpha pathway","volume":"953","author":"Ding","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.molimm.2024.04.011_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115643","article-title":"Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL\/lpr kidneys","volume":"298","author":"Du","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.molimm.2024.04.011_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3899\/jrheum.150437","article-title":"Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy","volume":"43","author":"Durcan","year":"2016","journal-title":"J. Rheumatol."},{"issue":"4","key":"10.1016\/j.molimm.2024.04.011_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna","year":"2013","journal-title":"Dent. Clin. North Am."},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/08916930903374832","article-title":"Key role of ERK pathway signaling in lupus","volume":"43","author":"Gorelik","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.molimm.2024.04.011_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gene.2018.05.041","article-title":"The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry","volume":"668","author":"Goulielmos","year":"2018","journal-title":"Gene"},{"issue":"7","key":"10.1016\/j.molimm.2024.04.011_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3949\/ccjm.87a.19039","article-title":"Glucocorticoid-induced osteoporosis: Insights for the clinician","volume":"87","author":"Hayat","year":"2020","journal-title":"Cleve Clin. J. Med."},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.intimp.2014.07.001","article-title":"Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL\/lpr mice","volume":"22","author":"Huang","year":"2014","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.molimm.2024.04.011_bib16","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.4049\/jimmunol.1102154","article-title":"Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice","volume":"188","author":"Iwata","year":"2012","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.molimm.2024.04.011_bib17","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.intimp.2011.04.015","article-title":"The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL\/lpr mouse model of systemic lupus","volume":"11","author":"Jin","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.molimm.2024.04.011_bib18","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/acr.24541","article-title":"Predictors of osteonecrosis in systemic lupus erythematosus: a prospective cohort study","volume":"74","author":"Kallas","year":"2022","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.molimm.2024.04.011_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","article-title":"Systemic lupus erythematosus: new diagnostic and therapeutic approaches","volume":"74","author":"Lazar","year":"2023","journal-title":"Annu. Rev. Med."},{"issue":"8","key":"10.1016\/j.molimm.2024.04.011_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","article-title":"Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation","volume":"6","author":"Li","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.molimm.2024.04.011_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2019.08.013","article-title":"Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2\/HO-1 pathway","volume":"143","author":"Li","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molimm.2024.04.011_bib22","article-title":"Dihydroartemisinin alleviates imiquimod-induced psoriasis-like skin lesion in mice involving modulation of IL-23\/Th17 axis","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"70","key":"10.1016\/j.molimm.2024.04.011_bib23","doi-asserted-by":"crossref","first-page":"115028","DOI":"10.18632\/oncotarget.22854","article-title":"Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3\/PI3K\/AKT\/NF-kappaB signaling pathway","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.molimm.2024.04.011_bib24","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST20220271","article-title":"ERK1\/2 in immune signalling","volume":"50","author":"Lucas","year":"2022","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.molimm.2024.04.011_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2019.06.009","article-title":"The contribution of macrophages to systemic lupus erythematosus","volume":"207","author":"Ma","year":"2019","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2024.04.011_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.autrev.2012.10.019","article-title":"p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris","volume":"12","author":"Mavropoulos","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.2008.102780","article-title":"Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus","volume":"69","author":"Molad","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.molimm.2024.04.011_bib28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11926-018-0764-y","article-title":"Artemisinins-a promising new treatment for systemic lupus erythematosus: a descriptive review","volume":"20","author":"Mu","year":"2018","journal-title":"Curr. Rheuma Rep."},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","article-title":"Immunological pathogenesis and treatment of systemic lupus erythematosus","volume":"16","author":"Pan","year":"2020","journal-title":"World J. Pedia"},{"key":"10.1016\/j.molimm.2024.04.011_bib30","article-title":"The role of immunometabolism in the pathogenesis of systemic lupus erythematosus","volume":"12","author":"Robinson","year":"2021","journal-title":"Front Immunol."},{"issue":"12","key":"10.1016\/j.molimm.2024.04.011_bib31","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1093\/rheumatology\/keab347","article-title":"Prednisone in systemic lupus erythematosus: taper quickly, withdraw slowly","volume":"60","author":"Ruiz-Irastorza","year":"2021","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.molimm.2024.04.011_bib32","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1177\/0961203320930099","article-title":"Seventy years after Hench's Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus","volume":"29","author":"Ruiz-Irastorza","year":"2020","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.molimm.2024.04.011_bib33","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s11033-021-07079-1","article-title":"Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation","volume":"49","author":"Wang","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13075-021-02620-w","article-title":"Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL\/lpr mice","volume":"23","author":"Wang","year":"2021","journal-title":"Arthritis Res Ther."},{"issue":"13","key":"10.1016\/j.molimm.2024.04.011_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24132475","article-title":"Dihydroartemisinin regulates the Th\/Treg balance by inducing activated CD4+ T cell apoptosis via heme oxygenase-1 induction in mouse models of inflammatory bowel disease","volume":"24","author":"Yan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.molimm.2024.04.011_bib36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.freeradbiomed.2016.10.498","article-title":"ROS-JNK1\/2-dependent activation of autophagy is required for the induction of anti-inflammatory effect of dihydroartemisinin in liver fibrosis","volume":"101","author":"Zhang","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib37","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13287-022-03174-7","article-title":"Mesenchymal stem cell-derived exosome-educated macrophages alleviate systemic lupus erythematosus by promoting efferocytosis and recruitment of IL-17(+) regulatory T cell","volume":"13","author":"Zhang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.molimm.2024.04.011_bib38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11427-019-9550-4","article-title":"Dihydroartemisinin regulates the immune system by promotion of CD8(+) T lymphocytes and suppression of B cell responses","volume":"63","author":"Zhang","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"5","key":"10.1016\/j.molimm.2024.04.011_bib39","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jbmr.2771","article-title":"Dihydroartemisinin, an anti-malaria drug, suppresses estrogen deficiency-induced osteoporosis, osteoclast formation, and rankl-induced signaling pathways","volume":"31","author":"Zhou","year":"2016","journal-title":"J. Bone Min. Res."},{"issue":"1","key":"10.1016\/j.molimm.2024.04.011_bib40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589024000804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589024000804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:01:36Z","timestamp":1738206096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589024000804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":40,"alternative-id":["S0161589024000804"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2024.04.011","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prednisone combined with Dihydroartemisinin attenuates systemic lupus erythematosus by regulating M1\/M2 balance through the MAPK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2024.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}